title: Brain-wide pathway for waste clearance captured by contrast-enhanced MRI.
abstract: The glymphatic system is a recently defined brain-wide paravascular pathway for cerebrospinal fluid (CSF) and interstitial fluid (ISF) exchange that facilitates efficient clearance of solutes and waste from the brain. CSF enters the brain along para-arterial channels to exchange with ISF, which is in turn cleared from the brain along para-venous pathways. Because soluble amyloid β clearance depends on glymphatic pathway function, we proposed that failure of this clearance system contributes to amyloid plaque deposition and Alzheimer's disease progression. Here we provide proof of concept that glymphatic pathway function can be measured using a clinically relevant imaging technique. Dynamic contrast-enhanced MRI was used to visualize CSF-ISF exchange across the rat brain following intrathecal paramagnetic contrast agent administration. Key features of glymphatic pathway function were confirmed, including visualization of para-arterial CSF influx and molecular size-dependent CSF-ISF exchange. Whole-brain imaging allowed the identification of two key influx nodes at the pituitary and pineal gland recesses, while dynamic MRI permitted the definition of simple kinetic parameters to characterize glymphatic CSF-ISF exchange and solute clearance from the brain. We propose that this MRI approach may provide the basis for a wholly new strategy to evaluate Alzheimer's disease susceptibility and progression in the live human brain.
authors: Center for Translational Neuromedicine, Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.
authors: Jeffrey J
authors: JJ
authors: Iliff
authors: Hedok
authors: H
authors: Lee
authors: Mei
authors: M
authors: Yu
authors: Tian
authors: T
authors: Feng
authors: Jean
authors: J
authors: Logan
authors: Maiken
authors: M
authors: Nedergaard
authors: Helene
authors: H
authors: Benveniste
mesh_terms: D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis; D000818:Animals; D001921:Brain / Q000378:metabolism*; D016000:Cluster Analysis; D003287:Contrast Media / Q000008:administration & dosage / Q000493:pharmacokinetics*; D045604:Extracellular Fluid / Q000378:metabolism; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D019786:Gadolinium DTPA / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D007278:Injections, Spinal; D008279:Magnetic Resonance Imaging / Q000379:methods*; D059906:Neuroimaging; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
chemical_list: D003287:Contrast Media; D019786:Gadolinium DTPA